financetom
Business
financetom
/
Business
/
Nanobiotix Doses First Patient in Phase 2 Study of Lung Cancer Therapy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nanobiotix Doses First Patient in Phase 2 Study of Lung Cancer Therapy
Jan 21, 2025 12:57 AM

03:39 AM EST, 01/21/2025 (MT Newswires) -- Nanobiotix ( NBTX ) said Tuesday it dosed the first patient in a phase 2 trial testing the experimental drug, JNJ-1900, for stage 3 non-small cell lung cancer.

The study is sponsored by Johnson & Johnson's ( JNJ ) subsidiary, Janssen Pharmaceutical, under a global licensing agreement.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RevSpring to Acquire Kyruus Health, Creating a Connected Care Journey from Search to Final Payment
RevSpring to Acquire Kyruus Health, Creating a Connected Care Journey from Search to Final Payment
Sep 23, 2025
Unified platform will support whole-person engagement while simplifying operations and improving financial outcomes for healthcare organizations NASHVILLE, Tenn., and BOSTON, Sept. 23, 2025 /PRNewswire/ -- RevSpring, a Frazier Healthcare portfolio company, is pleased to announce that it has entered into a definitive agreement to acquire Kyruus Health (Kyruus), a pioneer in provider data, search, and scheduling. The company plans to...
Nexstar Stations to Continue to Preempt Jimmy Kimmel Show
Nexstar Stations to Continue to Preempt Jimmy Kimmel Show
Sep 23, 2025
11:59 AM EDT, 09/23/2025 (MT Newswires) -- Nexstar Media Group ( NXST ) said Tuesday that its television stations and partners affiliated with Walt Disney's ( DIS ) ABC Television Network will not air the Jimmy Kimmel Live! show as it returns to ABC. Nexstar decided to preempt the show last week after ABC referred to Kimmel's ill-timed and insensitive...
Innovation Beverage Plans Potential Merger With BlockFuel Energy; Shares Rise
Innovation Beverage Plans Potential Merger With BlockFuel Energy; Shares Rise
Sep 23, 2025
11:54 AM EDT, 09/23/2025 (MT Newswires) -- Innovation Beverage Group ( IBG ) said Tuesday that it has signed a non-binding letter to merge with oil and gas exploration company BlockFuel Energy. The merger will be structured as a reverse triangular merger, with a newly formed subsidiary of Innovation Beverage ( IBG ) merging with BlockFuel Energy, with owners of...
--Street Color: Microsoft Says Has Developed In-Chip Microfluidic Cooling System
--Street Color: Microsoft Says Has Developed In-Chip Microfluidic Cooling System
Sep 23, 2025
11:57 AM EDT, 09/23/2025 (MT Newswires) -- Price: 510.49, Change: -3.97, Percent Change: -0.77 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved